ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » AMGN Stock Price » AMGN Stock News

Amgen Inc. Share News

 Amgen Inc. (mm) Stock Price
AMGN Stock Price
 Amgen Inc. (mm) Stock Chart
AMGN Stock Chart
 Amgen Inc. (mm) Stock News
AMGN Stock News
 Amgen Inc. (mm) Company Information
AMGN Company Information
 Amgen Inc. (mm) Stock Trades
AMGN Stock Trades

Amgen To Buy Mustafa Nevzat For $700 Million

Biotechnology firm Amgen (AMGN) will buy a 95.6% stake in Mustafa Nevzat Pharmaceuticals for $700 million, in a move to expand its presence in Turkey and the surrounding region. The all-cash transaction has been approved by both the boards, the two companies said in a joint statement Wednesday. MN, which supplies pharmaceuticals to the hospital sector and is a major supplier of injectable medicines in Turkey, had revenue of approximately $200 million in 2011, the statement said. Amgen's focus on Turkey and the surrounding region, which are large, fast-growing, priority markets for Amgen, is a part of its international expansion strategy. Amgen established an affiliate in Turkey in 2010 and currently markets two products, with plans to develop its pipeline of clinical candidates for Turkey and other markets around the world. Order free Annual Report for Amgen, Inc. Visit http://djnewswires.ar.wilink.com/?link=AMGN or call 1-888-301-0513

Stock News for Amgen Inc. (AMGN)
DateTimeHeadline
06/22/201618:00:00Amgen Sponsors QB3@953 Incubator For Life Science Startups
06/20/201608:25:00Biotechnology Stocks Under Review - Eleven Biotherapeutics, Relypsa...
06/17/201616:00:00Amgen Appoints Esteban Santos Executive Vice President, Operations
06/15/201616:58:28Annual Report of Employee Stock Plans (11-k)
06/15/201616:51:42Annual Report of Employee Stock Plans (11-k)
06/14/201616:55:30Current Report Filing (8-k)
06/13/201616:00:00Amgen Announces FDA Advisory Committee Meeting To Review ABP...
06/10/201616:00:00New Analyses From Pivotal Phase 3 Studies Show Kyprolis® (Carfilzomib...
06/10/201609:17:28Current Report Filing (8-k)
06/10/201609:00:00Amgen Announces Expiration And Final Results Of Senior Notes...
06/10/201602:30:00BLINCYTO® (Blinatumomab) Improved Overall Survival In Patients...
06/09/201616:18:40Statement of Changes in Beneficial Ownership (4)
06/08/201616:30:00Amgen Announces Erenumab (AMG 334) Significantly Reduces Patients...
06/07/201609:00:00New National Survey Sheds Light On How To Better Engage Students...
06/06/201616:00:00New Phase 3 Secondary Analysis Shows Progression-Free Survival...
06/06/201612:20:00Gilead's New CEO Faces Pressures on Hepatitis C Pills
06/03/201616:15:00Amgen Announces Launch Of KYPROLIS® (carfilzomib) CENTRAL, An...
06/03/201616:00:00Amgen To Present At The Goldman Sachs 37th Annual Global Healthcare...
06/01/201602:30:00Bayer Collaborates with U.S. National Surgical Adjuvant Breast...
05/31/201616:32:17Specialized Disclosure Report (sd)

Amgen Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad